Patient Preferences and Understanding of Genome‐Wide Cell‐Free DNA Screening for Foetal Chromosomal Imbalances: A Survey Study
Prenatal Diagnosis · 2025
DOI: 10.1002/pd.6842 ↗At a glance
Journal article in Prenatal Diagnosis, 2025. Written by Yvette Raymond and 7 co-authors. Institution: Department of Obstetrics and Gynecology, Monash University, Clayton, Australia. Major MEDLINE topics: Patient Preference, Cell-Free Nucleic Acids, Noninvasive Prenatal Testing, Prenatal Diagnosis. 37 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Objective
To assess parental preferences, expectations and understanding of genome‐wide cell‐free DNA screening (gwNIPT) in Australia.
Method
A cross‐sectional survey study utilizing an anonymous electronic questionnaire was conducted across three participating screening services in Australia between September 2023 and November 2024. Questions pertained to respondent demographics, pre‐screening counselling, and accuracy expectations of gwNIPT for various chromosomal anomalies. Statistical analyses to investigate associations between responses used Chi‐squared and Fisher's exact tests, ordinal logistic regression, and the Kruskal‐Wallis test.
Results
There were 329 survey responses recorded, of which 216 were completed (65.7%). The most frequent source of NIPT referral was a medical doctor (74.1%), and the most common duration of pre‐screening counselling was 5 minutes (41.0%). Respondents showed overwhelming interest in all anomalies included in gwNIPT as well as various phenotypic outcomes including those of uncertain clinical significance. Despite this, only a minority of patients were aware that they were undergoing genome‐wide screening (38.2%), and respondents did not anticipate a statistically significant difference in screening accuracy across different anomaly types ( p = 0.715).
Conclusion
Respondents undergoing gwNIPT indicated a preference to receive as much genetic information about their pregnancies as possible. Pre‐screening counselling should therefore include the limitations of gwNIPT.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Obstetrics and Gynecology, Monash University, Clayton, Australia.
- Monash Women's, Monash Health, Clayton, Australia.
- Monash Obstetrics, Clayton, Australia.
- Aberdeen Centre for Women's Health Research, University of Aberdeen, Aberdeen, UK.
- Department of Pediatrics, The University of Melbourne, Melbourne, Australia.
- Victorian Clinical Genetic Services Ltd, Parkville, Australia.
ORCID profiles: Yvette Raymond, Andrew McLennan
Cite
APA
Raymond, Y., Fernando, S., Mol, B. W., Menezes, M., McLennan, A., Meagher, S., Hill, A., & Rolnik, D. L. (2025). Patient Preferences and Understanding of Genome‐Wide Cell‐Free DNA Screening for Foetal Chromosomal Imbalances: A Survey Study. Prenatal Diagnosis. https://doi.org/10.1002/pd.6842
Vancouver
Raymond Y, Fernando S, Mol BW, Menezes M, McLennan A, Meagher S, et al. Patient Preferences and Understanding of Genome‐Wide Cell‐Free DNA Screening for Foetal Chromosomal Imbalances: A Survey Study. Prenatal Diagnosis. 2025. doi:10.1002/pd.6842
BibTeX
@article{Raymond2025,
author = {Raymond, Yvette and Fernando, Shavi and Mol, Ben W and Menezes, Melody and McLennan, Andrew and Meagher, Simon and Hill, Amy and Rolnik, Daniel L},
title = {Patient Preferences and Understanding of Genome‐Wide Cell‐Free DNA Screening for Foetal Chromosomal Imbalances: A Survey Study},
journal = {Prenatal Diagnosis},
year = {2025},
doi = {10.1002/pd.6842}
}
EUVIMED